- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 165
Sinochem sets up $143m fund
The chemical producer has formed a fund that will count Hubei Xingfa Chemicals as a limited partner, with new energy, materials and chemicals all on the agenda.
Dec 19, 2019Vector charts course to bankruptcy
Lockheed Martin is looking to buy some of Vector’s assets after the Kanematsu-backed microsatellite launch services provider filed for bankruptcy.
Dec 19, 2019DuPont locks in OxyMem acquisition
Saudi Aramco has exited wastewater treatment system developer OxyMem, which has been bought by another corporate investor, DuPont.
Dec 19, 2019SVO bowls over VTC for $15m round
VTC Innovation Fund took part in a $15m round for organic meat brand operator Shenandoah Valley Organic, bringing its total to $24.2m.
Dec 18, 2019Hanplatform hangs up series A funding
XCMG's industrial internet-of-things spinoff raised $42.9m from investors including Xinhua Daily Media Group, with Hillhouse Capital leading the round.
Dec 18, 2019A2A sees $78m fund on the horizon
A2A has formed a corporate venturing arm with $78m in funding, including a commitment from Polytechnic University of Milan’s university venture fund Poli360.
Dec 18, 2019Gecko Robotics gets $40m
Siemens subsidiary Next47 was among the investors that contributed to the robotics technology developer’s $40m series B round.
Dec 17, 2019VanLanduit moves to head up Tyson Ventures
Erin VanLanduit is taking on the managing director role at Tyson Ventures following the departures of Reese Schroeder and Tom Mastrobuoni.
Dec 17, 2019Huaqin hauls in $143m
Intel Capital, Qualcomm Ventures and Zhangjiang Hi-Tech all invested in the original design manufacturer as part of a round that valued it at more than $2bn.
Dec 16, 2019EHang lands on public markets in $40m IPO
Autonomous drone developer EHang floated at the bottom of its range in an initial public offering that allowed Lung Biotechnology and United Therapeutics to exit.
Dec 16, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


